Literature DB >> 8567622

Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32.

J A Lippke1, Y Gu, C Sarnecki, P R Caron, M S Su.   

Abstract

We have identified and characterized a novel cysteine protease named CMH-1 that is a new member of the interleukin 1 beta converting enzyme (ICE) family of proteases with substrate specificity for Asp-X. CMH-1 has the highest similarity to CPP32 (52% amino acid identity) and MCH2 (31% identical). CMH-1 shares conserved amino acid residues that form the core structure of ICE as well as those residues involved in catalysis and in the P1 aspartate binding. Overexpression of CMH-1 in COS cells resulted in the processing of CMH-1 and the induction of apoptosis of transfected cells. Coexpression of CMH-1 with poly(ADP-ribose) polymerase (PARP) also resulted in a specific cleavage of PARP. Purified recombinant CMH-1 cleaved PARP but not interleukin 1 beta precursor in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567622     DOI: 10.1074/jbc.271.4.1825

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Actin cleavage in various tumor cells is not a critical requirement for executing apoptosis.

Authors:  R L Rice; D G Tang; J D Taylor
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 2.  Apoptosis: a new pharmacodynamic endpoint.

Authors:  J L Au; N Panchal; D Li; Y Gan
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

3.  Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation.

Authors:  Dean A Le; Yongqin Wu; Zhihong Huang; Kohji Matsushita; Nikolaus Plesnila; Jean C Augustinack; Bradley T Hyman; Junying Yuan; Keisuke Kuida; Richard A Flavell; Michael A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

4.  FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

Authors:  J P Medema; C Scaffidi; F C Kischkel; A Shevchenko; M Mann; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

5.  Low cleaved caspase-7 levels indicate unfavourable outcome across all breast cancers.

Authors:  Andreas U Lindner; Federico Lucantoni; Damir Varešlija; Alexa Resler; Brona M Murphy; William M Gallagher; Arnold D K Hill; Leonie S Young; Jochen H M Prehn
Journal:  J Mol Med (Berl)       Date:  2018-08-01       Impact factor: 4.599

6.  Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites.

Authors:  B Joshi; S Rastogi; M Morris; L M Carastro; C DeCook; E Seto; S P Chellappan
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

7.  Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury.

Authors:  A G Yakovlev; S M Knoblach; L Fan; G B Fox; R Goodnight; A I Faden
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

8.  Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.

Authors:  H Hara; R M Friedlander; V Gagliardini; C Ayata; K Fink; Z Huang; M Shimizu-Sasamata; J Yuan; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

9.  PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition.

Authors:  Quinn P Peterson; David R Goode; Diana C West; Kara N Ramsey; Joy J Y Lee; Paul J Hergenrother
Journal:  J Mol Biol       Date:  2009-03-10       Impact factor: 5.469

10.  S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3.

Authors:  Saeid Ghavami; Mehdi Eshragi; Sudharsana R Ande; Walter J Chazin; Thomas Klonisch; Andrew J Halayko; Karol D McNeill; Mohammad Hashemi; Claus Kerkhoff; Marek Los
Journal:  Cell Res       Date:  2009-11-24       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.